1. Sabater S, Andres I, Lopez-Honrubia V et al. Vaginal cuff brachytherapy in endometrial cancer – a technically easy treatment? Cancer Manag Res 2017; 9: 351-362.
2.
Samper Ots PM, Rovirosa Casino A, Herreros Martínez A et al. Consensus and recommendations on vaginal-cuff Brachytherapy of the Spanish Brachytherapy Groups of SEOR and SEFM. Clin Trans Oncol 2021; 23: 1193-1200.
3.
Creutzberg CL, Nout RA. The role of radiotherapy in endometrial cancer: current evidence and trends. Curr Oncol Rep 2011; 13: 472-478.
4.
Gultekin M, Tugce Yilmaz M, Biltekin F et al. Adjuvant vaginal cuff brachytherapy: dosimetric comparison of conventional versus 3-dimensional planning in endometrial cancer. J Contemp Brachytherapy 2020; 12: 601-605.
5.
Morrow CP, Bundy BN, Kurman RJ et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 1991; 40: 55-65.
6.
Creutzberg CL, Nout RA, Lybeert MLM et al. Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma. Int J Radiat Oncol Biol Phys 2011; 81: e631-e638.
7.
Wortman BG, Creutzberg CL, Putter H et al. Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy. Br J Cancer 2018; 119: 1067-1074.
8.
Bosse T, Peters EEM, Creutzberg CL et al. Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer – a pooled analysis of PORTEC 1 and 2 trials. Eur J Cancer 2015; 51: 1742-1750.
9.
Viswanathan AN, Macklin EA, Berkowitz R et al. The importance of chemotherapy and radiation in uterine papillary serous carcinoma. Gynecol Oncol 2011; 123: 542-547.
10.
Tatebe K, Hasan Y, Son CH. Adjuvant vaginal brachytherapy and chemotherapy versus pelvic radiotherapy in early-stage endometrial cancer: outcomes by risk factors. Gynecol Oncol 2019; 155: 429-435.
11.
Nout RA, Smit VTHBM, Putter H et al. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. Lancet 2010; 375: 816-823.
12.
Glaser SM, Kim H, Beriwal S. Multichannel vaginal cylinder brachytherapy – Impact of tumor thickness and location on dose to organs at risk. Brachytherapy 2015; 14: 913-918.
13.
Kim H, Rajagopalan MS, Houser C, Beriwal S. Dosimetric comparison of multichannel with one single-channel vaginal cylinder for vaginal cancer treatments with high-dose-rate brachytherapy. Brachytherapy 2014; 13: 263-267.
14.
Mohammadi R, Siavashpour Z, Hosseini Aghdam SR et al. Manufacturing and evaluation of multi-channel cylinder applicator with 3D printing technology. J Contemp Brachytherapy 2021; 13: 80-90.
15.
Iftimia I, Cirino ET, Mower HW et al. Treatment planning methodology for the Miami Multichannel Applicator following the American Brachytherapy Society recently published guidelines: the Lahey Clinic experience. J Appl Clin Med Phys 2013; 14: 214-227.
16.
Beriwal S, Bhatnagar A, Heron DE et al. High-dose-rate interstitial brachytherapy for gynecologic malignancies. Brachytherapy 2006; 5: 218-222.
17.
Biltekin F, Akyol H, Gültekin M, Yildiz F. 3D printer-based novel intensity-modulated vaginal brachytherapy applicator: feasibility study. J Contemp Brachytherapy 2020; 12: 17-26.
18.
Gay HA, Barthold HJ, O’Meara et al. Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlas. Int J Radiat Oncol Biol Phys 2012; 83: e353-e362.
19.
Demanes DJ, Rege S, Rodriquez RR et al. The use and advantages of a multichannel vaginal cylinder in high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 1999; 44: 211-219.
20.
Tanderup K, Lindegaard JC. Multi-channel intracavitary vaginal brachytherapy using three-dimensional optimization of source geometry. Radiother Oncol 2004; 70: 81-85.
21.
Govindaraj K, Shanmugam S, Sampathrajan S. Design and development of in-house multichannel applicator for HDR vaginal brachytherapy and dosimetric comparision with single channel applicator. Asian Pac J Cancer Prev 2019; 20: 3805-3810.
22.
Sohn JJ, Polizzi M, Kang SW et al. Intensity modulated high dose rate (HDR) brachytherapy using patient specific 3d metal printed applicators: proof of concept. Front Oncol 2022; 12: 829529.
23.
Callaghan CM, Adams Q, Flynn RT et al. Systematic review of intensity-modulated brachytherapy (IMBT): static and dynamic techniques. Int J Radiat Oncol Biol Phys 2019; 105: 206-221.
24.
Bahadur YA, Constantinescu C, Hassouna AH et al. Single versus multichannel applicator in high-dose-rate vaginal brachytherapy optimized by inverse treatment planning. J Contemp Brachytherapy 2015; 6: 362-370.
25.
Small Jr W, Beriwal S, Demanes DJ et al. American Brachytherapy Society consensus guidelines for adjuvant vaginal cuff brachytherapy after hysterectomy. Brachytherapy 2012; 11: 58-67.
26.
Skinner LB, Niedermayr T, Prionas N et al. Intensity modulated Ir-192 brachytherapy using high-Z 3D printed applicators. Phys Med Biol 2020; 65: 155018.
